inVentiv Health Named A Top CRO From Among 2,000 Investigative Sites Surveyed By CenterWatch

inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, recently announced that inVentiv Healthl had been rated a Top CRO in a bi-annual survey by CenterWatch, a leading provider of global clinical trial information.

This is the second time this year inVentiv Healthl has received prestigious industry recognition. Earlier this year, Pharma Times named the inVentiv Healthl as “Clinical Company of the Year.” The CenterWatch 2013 Global Investigative Site Relationship Survey asked investigative sites to rate their clinical trial relationships with CROs. More than 2,000 investigative sites ranked CROs across 36 different relationship attributes and rankings were then based on the number of “excellent” scores each CRO received. inVentiv Clinical rated among the top three CROs.

“To ensure the successful implementation of our clinical trials, we place a very high importance on developing strong collaborative relationships with our investigative site partners,” said Ray Hill, President of inVentiv Healthl. “It is gratifying to see these efforts recognized by the investigative sites themselves.”

The full report is available in the May issue of The CenterWatch Monthly Newsletter (http://centerwatch.com/).
As part of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services, inVentiv Healthl is uniquely positioned to offer healthcare companies worldwide services in Early Stage (Phase I), Phase II-III, Late Stage (Phase IV) clinical development and clinical staffing. With 7,000 employees in more than 70 countries, inVentiv Healthl’s services can be deployed on any scale from highly complex multinational clinical trials to earlier stage studies involving specialized patient populations to Late Stage post-approval studies, or from placing a single individual at a company to outsourcing a full clinical department. With such broad capabilities, global reach and focus on strong relationships, the company has developed a growing reputation as one of the world’s leading CROs.

CenterWatch is a leading source of clinical trials information for both clinical research professionals and patients. The consulting services and news company is recognized by many of the top media outlets and publications around the world as a leading authority and source of information on the clinical trials industry.

About inVentiv Healthl
inVentiv Healthl, formerly PharmaNet/i3, is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies, offering therapeutically specialized capabilities for Phase I-IV clinical development, bioanalytical services, and strategic resourcing from a single clinical professional to an entire functional team. With 7,000 employees operating in more than 70 countries, inVentiv Healthl works to accelerate high quality drug development programs of all sizes around the world. For more information, visit http://www.inventivhealthclinical.com

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. In 40 countries around the world, inVentiv’s 13,000 employees help clients rapidly transform promising ideas into commercial reality. inVentiv clients include more than 550 pharmaceutical, biotech and life sciences companies, as well as companies that now see health as part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.